Trice Medical

Trice Medical is a commercial-stage medical device company focused on advancing minimally invasive procedures in orthopedics, sports medicine, and podiatry. Its flagship Tenex system utilizes ultrasonic technology to remove diseased soft tissue for conditions like tendinopathy and plantar fasciitis, offering an alternative to open surgery. The company complements this with the Seg-WAY endoscopic carpal tunnel release system and the mi-eye 3 portable arthroscopy platform. Trice's value proposition centers on simplifying complex procedures, reducing surgical and recovery time, and improving patient outcomes through less invasive techniques.

Minimally invasive platforms including ultrasonic percutaneous tissue removal (Tenex), high-resolution portable needlescope arthroscopy (mi-eye 3), and endoscopic ligament release systems (Seg-WAY).

Trice competes in the minimally invasive orthopedic device space against giants like Stryker, Smith & Nephew, and Arthrex, which have vast resources and broad portfolios. It also faces competition from other niche players offering ultrasonic tenotomy (e.g., Tenex Health TX2 system, now part of ConMed) and endoscopic release systems. Differentiation is based on technology efficacy, clinical evidence, ease of use, and surgeon training support.